uniQure

un1Qure Genezen

Biotech

uniQure stock crashes as Huntington’s gene therapy data weaken

Mitigating circumstances and the ongoing strength of a secondary endpoint kept analysts optimistic about AMT-130’s path to approval.

Nick Paul Taylor Sep 29, 2026 9:28am

red light green light

UniQure stock surges after FDA U-turn clears path to filing

Jun 17, 2026 9:10am

two arrows pointing different directions

Fierce Pharma

FDA to reconsider rejected cell therapy. Could uniQure be next?

May 7, 2026 10:40am

light bulb think theory idea bright dull lights out

Small pools, big ideas: Rare disease community reimagines trials

Apr 17, 2026 3:00am

The Capitol Building in Washington DC with bright blue sky - stock photo Becky WrightGetty Images

‘Bureaucratic idiocy’: GOP senator to investigate FDA rejections

Mar 10, 2026 11:10am

FDA stop sign

Senior FDA official fires back at uniQure amid controversy

Mar 5, 2026 3:33pm